Literature DB >> 1694056

Antibody L26 recognizes an intracellular epitope on the B-cell-associated CD20 antigen.

D Y Mason1, W M Comans-Bitter, J L Cordell, M A Verhoeven, J J van Dongen.   

Abstract

Monoclonal antibody L26 is a highly selective marker of B cells and B-cell neoplasms in paraffin-embedded tissues, but it suffers from the drawback that the target molecule has not been identified. In this paper we provide evidence by two independent techniques that antibody L26 recognizes an intracellular epitope on the CD20 antigen (a pan B-cell marker). When this antigen was redistributed on the surface of unfixed viable B cells by incubation with monoclonal anti-CD20 followed by anti-mouse Ig, the diffuse cytoplasmic staining of L26 was abolished and replaced by coincident dotlike labeling for antibody L26 and the CD20 antigen. None of the other antibodies tested (covering 10 different B-cell-associated antigens) had this effect on the L26 staining pattern. Furthermore, COS-1 cells transfected with cDNA encoding the CD20 molecule gave positive staining with antibody L26 and with two other CD20 reagents, but not with antibodies to other pan B-cell markers (eg, CD19 and CD22).

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1694056      PMCID: PMC1877587     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  15 in total

1.  Antisera against epitopes resistant to denaturation on T3 (CD3) antigen can detect reactive and neoplastic T cells in paraffin embedded tissue biopsy specimens.

Authors:  D Y Mason; G W Krissansen; F R Davey; M J Crumpton; K C Gatter
Journal:  J Clin Pathol       Date:  1988-02       Impact factor: 3.411

2.  Structure of the gene encoding the human B lymphocyte differentiation antigen CD20 (B1).

Authors:  T F Tedder; G Klejman; S F Schlossman; H Saito
Journal:  J Immunol       Date:  1989-04-01       Impact factor: 5.422

3.  Leu-22: a preferential marker for T-lymphocytes in paraffin sections. Staining profile in T- and B-cell lymphomas, Hodgkin's disease, other lymphoproliferative disorders, myeloproliferative diseases, and various neoplastic processes.

Authors:  J W Said; P N Stoll; P Shintaku; J M Bindl; J R Butmarc; G S Pinkus
Journal:  Am J Clin Pathol       Date:  1989-05       Impact factor: 2.493

4.  Immunophenotypic diagnosis of non-Hodgkin's lymphoma in paraffin sections. Co-expression of L60 (Leu-22) and L26 antigens correlates with malignant histologic findings.

Authors:  B Y Ngan; L J Picker; L J Medeiros; R A Warnke
Journal:  Am J Clin Pathol       Date:  1989-05       Impact factor: 2.493

5.  Immunophenotyping of leukaemias and non-Hodgkin's lymphomas. Immunological markers and their CD codes.

Authors:  J J van Dongen; H J Adriaansen; H Hooijkaas
Journal:  Neth J Med       Date:  1988-12       Impact factor: 1.422

6.  Immunophenotyping of non-Hodgkin's lymphomas using a panel of antibodies on paraffin-embedded tissues.

Authors:  F R Davey; K C Gatter; E Ralfkiaer; K A Pulford; G W Krissansen; D Y Mason
Journal:  Am J Pathol       Date:  1987-10       Impact factor: 4.307

7.  Utilization of monoclonal antibody L26 in the identification and confirmation of B-cell lymphomas. A sensitive and specific marker applicable to formalin-and B5-fixed, paraffin-embedded tissues.

Authors:  R W Cartun; F B Coles; W T Pastuszak
Journal:  Am J Pathol       Date:  1987-12       Impact factor: 4.307

8.  Monoclonal antibody L26: an antibody that is reactive with normal and neoplastic B lymphocytes in routinely fixed and paraffin wax embedded tissues.

Authors:  A J Norton; P G Isaacson
Journal:  J Clin Pathol       Date:  1987-12       Impact factor: 3.411

9.  Two distinct antigen systems in human B lymphocytes: identification of cell surface and intracellular antigens using monoclonal antibodies.

Authors:  Y Ishii; T Takami; H Yuasa; T Takei; K Kikuchi
Journal:  Clin Exp Immunol       Date:  1984-10       Impact factor: 4.330

Review 10.  Lymphoma phenotyping in formalin-fixed and paraffin wax-embedded tissues: II. Profiles of reactivity in the various tumour types.

Authors:  A J Norton; P G Isaacson
Journal:  Histopathology       Date:  1989-06       Impact factor: 5.087

View more
  33 in total

1.  T lymphocytes expressing HECA-452 epitope are present in cutaneous acute graft-versus-host disease and erythema multiforme, but not in acute graft-versus-host disease in gut organs.

Authors:  R E Davis; B R Smoller
Journal:  Am J Pathol       Date:  1992-09       Impact factor: 4.307

2.  Epigenetic regulation of CD20 protein expression in a novel B-cell lymphoma cell line, RRBL1, established from a patient treated repeatedly with rituximab-containing chemotherapy.

Authors:  Akihiro Tomita; Junji Hiraga; Hitoshi Kiyoi; Manabu Ninomiya; Takumi Sugimoto; Masafumi Ito; Tomohiro Kinoshita; Tomoki Naoe
Journal:  Int J Hematol       Date:  2007-07       Impact factor: 2.490

3.  Detection of inflammatory cytokine messenger RNA (mRNA)-expressing cells in human inflamed gingiva by combined in situ hybridization and immunohistochemistry.

Authors:  Y Matsuki; T Yamamoto; K Hara
Journal:  Immunology       Date:  1992-05       Impact factor: 7.397

4.  The bcl-2 gene translocation is undetectable in Hodgkin's disease by Southern blot hybridization and polymerase chain reaction.

Authors:  E Athan; A Chadburn; D M Knowles
Journal:  Am J Pathol       Date:  1992-07       Impact factor: 4.307

5.  Properties of human thymic B cells.

Authors:  J Spencer; M Choy; T Hussell; L Papadaki; J P Kington; P G Isaacson
Journal:  Immunology       Date:  1992-04       Impact factor: 7.397

6.  Expression of vascular cell adhesion molecule (VCAM-1) in liver and pancreas allograft rejection.

Authors:  C E Bacchi; C L Marsh; J D Perkins; R L Carithers; J P McVicar; K L Hudkins; C D Benjamin; J M Harlan; R Lobb; C E Alpers
Journal:  Am J Pathol       Date:  1993-02       Impact factor: 4.307

7.  Thymus development in Macaca fascicularis (Cynomolgus monkey): an approach for toxicology and embryology.

Authors:  Eberhard Buse; Gunnar Habermann; Friedhelm Vogel
Journal:  J Mol Histol       Date:  2006-09-19       Impact factor: 2.611

8.  Distribution of VLA integrins in solid tumors. Emergence of tumor-type-related expression. Patterns in carcinomas and sarcomas.

Authors:  M Miettinen; R Castello; E Wayner; R Schwarting
Journal:  Am J Pathol       Date:  1993-04       Impact factor: 4.307

9.  CD20 mutations involving the rituximab epitope are rare in diffuse large B-cell lymphomas and are not a significant cause of R-CHOP failure.

Authors:  Nathalie A Johnson; Stephen Leach; Bruce Woolcock; Ronald J deLeeuw; Ali Bashashati; Laurie H Sehn; Joseph M Connors; Mukesh Chhanabhai; Angela Brooks-Wilson; Randy D Gascoyne
Journal:  Haematologica       Date:  2009-02-11       Impact factor: 9.941

10.  Monoclonal antibodies EBU-141 (CDw75) and EBU-65 allow reliable distinction between mature and pre-B-cell tumors in suspension and on tissue sections.

Authors:  M Gramatzki; R Burger; J Kraus; U Lauer; P Rohwer; G Eger; J R Kalden; F Henschke
Journal:  Ann Hematol       Date:  1991-07       Impact factor: 3.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.